Verywell Health on MSN
The TP53 gene and its role in cancer
The TP53 gene is mutated in around 50% of cancer cells, but in addition to its role in tumor suppression, cancer cells ...
Targeting EGFR in glioblastoma: Preclinical testing of dacomitinib. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback